AgingResearch.NewsJoin free

Sulfated fuco-manno-glucuronogalactan

Intervention

1 paper studies it2 findings

Across all fields, 1 paper: none in people yet, 1 in animals

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Chinese Academy of Sciences and 4 more
  • Animals1

Outcomes

2

Glucose-stimulated insulin secretion

upin animals1

1 study

  1. Sulfated fuco-manno-glucuronogalactan improves glucose-stimulated insulin secretion.

    “SFGG also alleviated beta cell dysfunction in insulin synthesis and glucose-stimulated insulin secretion.”

    Animalsin vitro and in vivo

    Sulfated fuco-manno-glucuronogalactan alleviates pancreatic beta cell senescence via PI3K/AKT/FoxO1 pathway

    International journal of biological macromolecules

Cellular senescence

downin animals1

1 study

  1. Sulfated fuco-manno-glucuronogalactan decreases cellular senescence.

    “SFGG effectively alleviated senescence-related phenotypes in vitro and in vivo, including cell cycle, senescence-associated β-galactosidase, DNA damage and senescence-associated secretory phenotype (SASP) -associated cytokines”

    Animalspancreatic beta cell senescence

    Sulfated fuco-manno-glucuronogalactan alleviates pancreatic beta cell senescence via PI3K/AKT/FoxO1 pathway

    International journal of biological macromolecules

More on Cellular senescence

Latest

Related